Results 41 to 50 of about 4,512,082 (135)

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +2 more sources

Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report

open access: yesRadiology Case Reports, 2023
Epithelioid hemangioendothelioma (EHE) of the liver is an extremely rare malignant tumor of vascular origin, representing less than 1 % of all vascular tumors. Nearly 260 cases have been reported in English literature.
James R. Marak, MBBS, MD   +3 more
doaj   +1 more source

Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass

open access: yesRare Tumors, 2009
Primary hepatic angiosarcoma is a rare and rapidly fatal disease. We present the highly unusual identification of this lesion five years after the initial clinical presentation.
Jessica L Cioffi-Pretti   +3 more
doaj   +1 more source

Two‐Decade Trends in Radiotherapy Patterns and Clinical Outcomes for Soft Tissue Sarcoma: A Nationwide Study in South Korea (2005–2023)

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Soft tissue sarcoma (STS) is a rare malignancy with increasing utilization of advanced radiotherapy (RT). We evaluated nationwide transitions in RT patterns and clinical outcomes for STS in South Korea, focusing on the impact of national healthcare policies. Methods Utilizing the National Health Insurance Service database (2005–2023)
Tae Hyung Kim   +5 more
wiley   +1 more source

Advanced diffuse hepatic angiosarcoma treated successfully with TACE and targeted immunotherapy: A case report

open access: yesFrontiers in Oncology, 2023
Primary hepatic angiosarcoma (PHA), a rare soft tissue tumor, accounts for only 2% of all liver malignancies. Pathologically challenging, PHA is difficult to be distinguished from other malignancies with ultrasound, Computed Tomography (CT), or Magnetic ...
Yucheng Lin   +6 more
doaj   +1 more source

Primary Pulmonary Angiosarcoma: Case Report and Literature Review

open access: yesRespirology Case Reports, Volume 14, Issue 7, July 2026.
We present a case of primary pulmonary angiosarcoma with widespread metastatic disease, initially presenting with nonspecific respiratory symptoms and diagnostic uncertainty, ultimately diagnosed via robotic navigational bronchoscopy. This case highlights the challenges in early recognition and the potential role of advanced bronchoscopic techniques in
Shafaq Jawed, Sarva Sivatej
wiley   +1 more source

An Autopsy Case of Ruptured Hepatic Angiosarcoma Treated by Transcatheter Arterial Embolization [PDF]

open access: yes, 2023
An 80-year-old Japanese man presented to our hospital with intra-abdominal hemorrhage due to a ruptured liver tumor. Transcatheter arterial embolization (TAE) temporarily achieved hemostasis, but he died following re-rupture 4 days later.
Toshiki Entani   +6 more
core   +1 more source

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or metastatic sarcoma. Methods This pooled analysis included patients from seven investigator‐
Adel Shahnam   +16 more
wiley   +1 more source

Primary Hepatic Angiosarcoma

open access: yes, 2018
Primary hepatic angiosarcoma is a rare entity, representing only 4% of all the angiosarcomas of different origins1 and less than 1% of all hepatic malignancies.2 Accurate diagnosis of this tumour is difficult, especially if the patient has no history
Giovannini I   +4 more
core   +1 more source

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy